Literature DB >> 22222636

The spectrum of B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and classical Hodgkin lymphoma: a description of 10 cases.

Gabriela Gualco1, Yasodha Natkunam, Carlos E Bacchi.   

Abstract

B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and classical Hodgkin lymphoma, is a diagnostic provisional category in the World Health Organization (WHO) 2008 classification of lymphomas. This category was designed as a measure to accommodate borderline cases that cannot be reliably classified into a single distinct disease entity after all available morphological, immunophenotypical and molecular studies have been performed. Typically, these cases share features intermediate between diffuse large B-cell lymphoma and classical Hodgkin lymphoma, or include characteristics of both lymphomas. The rarity of such cases poses a tremendous challenge to both pathologists and oncologists because its differential diagnosis has direct implications for management strategies. In this study, we present 10 cases of B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and classical Hodgkin lymphoma and have organized the criteria described by the WHO into four patterns along with detailed clinical, morphological and immunophenotypic characterization and outcome data. Our findings show a male preponderance, median age of 37 years and a mediastinal presentation in 80% of cases. All cases expressed at least two markers associated with B-cell lineage and good response to combination chemotherapy currently employed for non-Hodgkin lymphomas.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22222636     DOI: 10.1038/modpathol.2011.200

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  14 in total

Review 1.  Selective immunophenotyping for diagnosis of B-cell neoplasms: immunohistochemistry and flow cytometry strategies and results.

Authors:  Scott D Boyd; Yasodha Natkunam; John R Allen; Roger A Warnke
Journal:  Appl Immunohistochem Mol Morphol       Date:  2013-03

2.  Gene expression profiling of gray zone lymphoma.

Authors:  Clémentine Sarkozy; Lauren Chong; Katsuyoshi Takata; Elizabeth A Chavez; Tomoko Miyata-Takata; Gerben Duns; Adèle Telenius; Merrill Boyle; Graham W Slack; Camille Laurent; Pedro Farinha; Thierry J Molina; Christiane Copie-Bergman; Diane Damotte; Gilles A Salles; Anja Mottok; Kerry J Savage; David W Scott; Alexandra Traverse-Glehen; Christian Steidl
Journal:  Blood Adv       Date:  2020-06-09

3.  Distinct isoform of FABP7 revealed by screening for retroelement-activated genes in diffuse large B-cell lymphoma.

Authors:  Frances E Lock; Rita Rebollo; Katharine Miceli-Royer; Liane Gagnier; Sabrina Kuah; Artem Babaian; Maialen Sistiaga-Poveda; C Benjamin Lai; Oksana Nemirovsky; Isabel Serrano; Christian Steidl; Mohammad M Karimi; Dixie L Mager
Journal:  Proc Natl Acad Sci U S A       Date:  2014-08-11       Impact factor: 11.205

4.  EBV-Positive Grey Zone Lymphoma in an HIV Infected Man from Kampala, Uganda: Case Report.

Authors:  Lynette K Tumwine; Jackson Orem; Leona W Ayers
Journal:  Int J Med Pharm Case Reports       Date:  2014-11-15

5.  Gray zone lymphoma effectively treated with cyclophosphamide, doxorubicin, vincristine, prednisolone, and rituximab chemotherapy: A case report.

Authors:  Nobumasa Hojo; Makoto Nagasaki; Yasuha Mihara
Journal:  World J Clin Cases       Date:  2022-06-16       Impact factor: 1.534

6.  Mediastinal gray zone lymphoma: clinico-pathological characteristics and outcomes of 99 patients from the Lymphoma Study Association.

Authors:  Clémentine Sarkozy; Thierry Molina; Hervé Ghesquières; Anne-Sophie Michallet; Jehan Dupuis; Diane Damotte; Franck Morsschauser; Marie Parrens; Laurent Martin; Peggy Dartigues; Aspasia Stamatoullas; Pierre Hirsch; Bettina Fabiani; Krimo Bouabdallah; Maria Gomes da Silva; Marie Maerevoet; Camille Laurent; Bertrand Coiffier; Gilles Salles; Alexandra Traverse-Glehen
Journal:  Haematologica       Date:  2016-10-06       Impact factor: 9.941

7.  B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and classical Hodgkin lymphoma without mediastinal disease: mimicking nodular sclerosis classical Hodgkin lymphoma.

Authors:  Noriko Iwaki; Yasuharu Sato; Toshiro Kurokawa; Yoshinobu Maeda; Kyotaro Ohno; Mai Takeuchi; Katsuyoshi Takata; Yorihisa Orita; Shinji Nakao; Tadashi Yoshino
Journal:  Med Mol Morphol       Date:  2013-03-20       Impact factor: 2.309

8.  Treatment of grey zone lymphoma using the R-CODOX-M/R-IVAC protocol: Two case reports.

Authors:  Xiao-Yan Yang; Ling Jiang; Rong-Fei Jia; An-Ji Hou
Journal:  Medicine (Baltimore)       Date:  2017-09       Impact factor: 1.889

9.  B Cell Lymphoma, Unclassifiable, Transformed from Follicular Lymphoma: A Rare Presentation with Review of the Literature.

Authors:  Anila Kanna; Swati Agrawal; Kumar Jayant; Varun Kumar Pala; Mohammad Altujjar; Tarik Hadid; Muhammad Khurram
Journal:  Case Rep Hematol       Date:  2015-08-26

10.  Comparison of pediatric and adult lymphomas involving the mediastinum characterized by distinctive clinicopathological and radiological features.

Authors:  Lei Chen; Mingsong Wang; Hua Fan; Fengqing Hu; Tingting Liu
Journal:  Sci Rep       Date:  2017-05-31       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.